Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

During the Trading Day
367.48 +1.51 / +0.41%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
363.00 -4.48 / -1.22%
Volume: 83.0K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues445.8M1.4B2.1B2.8B
Cost of Goods Sold4.2M84.5M155.4M205.0M
Depreciation And Amortization31.1M36.9M41.2M52.7M
Operating ExpensesGross Income410.5M1.3B1.9B2.6B
General Expenses615.7M796.6M1.1B1.7B
Research And Development498.4M588.6M818.7M1.2B
Total Operating Expenses651.0M918.0M1.3B2.0B
Non-Operating ExpensesOperating Income-205.2M460.5M760.5M838.4M
Extraordinary Credit0.
Extraordinary Charge0.000.00-2.9M-33.5M
Interest Expense On Debt21.3M45.3M46.4M43.6M
Other Expenses0.00-2.8M-499.0K1.2M
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-222.9M414.4M713.4M775.7M
Income Taxes-1.1M-335.8M-289.0M-427.7M
Net Income-221.8M750.3M424.4M348.1M
Shares To Calculate EPSShares To Calculate EPS90.6M94.7M97.9M100.6M
Shares To Calculate EPS Diluted90.6M115.4M111.3M113.4M
Earnings Per ShareEPS-$2.45$6.75$3.81$3.07
EPS Diluted-$2.45$6.75$3.81$3.07